Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Cathy Lanagan"'
Autor:
Nicholas K. Hayward, Adrian Herington, Christopher W. Schmidt, Graham J. Mann, Richard A. Scolyer, Michael O'Rourke, Linda O'Connor, Candace D. Carter, Cathy Lanagan, Gulietta M. Pupo, Varsha Tembe, Lauren G. Aoude, Priscilla Hunt, Darryl Irwin, Ken Dutton-Regester
PDF file - 381K, Results of Melanoma Specific Mutation Panel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e49f127f46d31f1a7e8a082213120e2
https://doi.org/10.1158/1535-7163.22498506.v1
https://doi.org/10.1158/1535-7163.22498506.v1
Autor:
Nicholas K. Hayward, Adrian Herington, Christopher W. Schmidt, Graham J. Mann, Richard A. Scolyer, Michael O'Rourke, Linda O'Connor, Candace D. Carter, Cathy Lanagan, Gulietta M. Pupo, Varsha Tembe, Lauren G. Aoude, Priscilla Hunt, Darryl Irwin, Ken Dutton-Regester
PDF file - 270K, Mutation List used in confirmation phase.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcb243245fc9670743337153451a2fba
https://doi.org/10.1158/1535-7163.22498509.v1
https://doi.org/10.1158/1535-7163.22498509.v1
Autor:
Nicholas K. Hayward, Adrian Herington, Christopher W. Schmidt, Graham J. Mann, Richard A. Scolyer, Michael O'Rourke, Linda O'Connor, Candace D. Carter, Cathy Lanagan, Gulietta M. Pupo, Varsha Tembe, Lauren G. Aoude, Priscilla Hunt, Darryl Irwin, Ken Dutton-Regester
XLS file - 50K, Confirmation panel assay design.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799241d09ae0553977b57bf1cf7b62b3
https://doi.org/10.1158/1535-7163.22498512
https://doi.org/10.1158/1535-7163.22498512
Autor:
Varsha Tembe, Christopher W. Schmidt, Gulietta M. Pupo, Ken Dutton-Regester, Nicholas K. Hayward, Priscilla Hunt, Graham J. Mann, Cathy Lanagan, Darryl Irwin, Candace D. Carter, Lauren G. Aoude, Michael G. E. O'Rourke, Linda O'Connor, Adrian C. Herington, Richard A. Scolyer
Publikováno v:
Molecular Cancer Therapeutics. 11:888-897
Success with molecular-based targeted drugs in the treatment of cancer has ignited extensive research efforts within the field of personalized therapeutics. However, successful application of such therapies is dependent on the presence or absence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96765b03040d76c4f50c25dfb041fa7a
https://doi.org/10.1158/1535-7163.mct-11-0676
https://doi.org/10.1158/1535-7163.mct-11-0676
Autor:
Richard A. Scolyer, Cathy Lanagan, Graham J. Mann, Michael G. E. O'Rourke, Ken Dutton-Regester, Lauren G. Aoude, Derek J. Nancarrow, Adrian C. Herington, Nicholas K. Hayward, Christopher W. Schmidt, Gulietta M. Pupo, Linda O'Connor, Mitchell S. Stark, Candace D. Carter, Varsha Tembe
Publikováno v:
Genes, Chromosomes and Cancer. 51:452-461
High density SNP arrays can be used to identify DNA copy number changes in tumors such as homozygous deletions of tumor suppressor genes and focal amplifications of oncogenes. Illumina Human CNV370 Bead chip arrays were used to assess the genome for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56d549e5a5a3df07283869fa247e8bae
https://doi.org/10.1002/gcc.21932
https://doi.org/10.1002/gcc.21932
Autor:
Mitchell S. Stark, Christopher W. Schmidt, Graham J. Mann, Ken Dutton-Regester, Lauren E. Haydu, Cathy Lanagan, Peter Johansson, Gulietta M. Pupo, Richard A. Scolyer, Linda O'Connor, Michael Gartside, Hojabr Kakavand, Varsha Tembe, John F. Thompson, Lauren G. Aoude, Nicholas K. Hayward
Publikováno v:
Pigment cellmelanoma research. 26(6)
Melanoma of unknown primary (MUP) is an uncommon phenomenon whereby patients present with metastatic disease without an evident primary site. To determine their likely site of origin, we combined exome sequencing from 33 MUPs to assess the total rate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ef1345aaf17f663d2fee39615de6d40
https://pubmed.ncbi.nlm.nih.gov/23890154
https://pubmed.ncbi.nlm.nih.gov/23890154
Autor:
Douglas F. Easton, Linda O'Connor, Bruce K. Armstrong, Jane M. Palmer, Victoria Zismann, Elizabeth A. Holland, Nicholas K. Hayward, Helen Schmid, Graham G. Giles, Vanessa F. Bonazzi, Megan Ferguson, Rizwan Haq, Michael Gartside, Graham J. Mann, Matthew Law, Paul D.P. Pharoah, Mitchell S. Stark, Stuart MacGregor, Kelly Holohan, Susan L. Woods, D. Timothy Bishop, Joanne F. Aitken, Jodie Jetann, Christopher W. Schmidt, Kevin M. Brown, David C. Whiteman, David L. Duffy, Judith Symmons, John C. Taylor, Alison M. Dunning, Glen M. Boyle, Grant W. Montgomery, Ken Dutton-Regester, Julia Newton-Bishop, Satoru Yokoyama, Lauren G. Aoude, Cathy Lanagan, David E. Fisher, Judith A. Maskiell, Mark Harland, John L. Hopper, Nicholas G. Martin, Richard F. Kefford, Jeffrey M. Trent, Mark A. Jenkins, Anne E. Cust, Hensin Tsao
Publikováno v:
Nature. 480(7375)
So far, two genes associated with familial melanoma have been identified, accounting for a minority of genetic risk in families. Mutations in CDKN2A account for approximately 40% of familial cases, and predisposing mutations in CDK4 have been reporte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76fcff51e7b0d9eba067ef1867ae0b12
https://pubmed.ncbi.nlm.nih.gov/22216437
https://pubmed.ncbi.nlm.nih.gov/22216437